Pharma Journalist 8969 posts 0 comments

Pfizer Inc. announced that the United States (U.S.) Food and Drug Administration (FDA) approved XELJANZ (tofacitinib) 10 mg twice-daily (BID) for at least eight weeks, followed by…
Read More...

Five Prime Therapeutics announced it has entered into a collaboration with Roche to develop immunohistochemistry (IHC) companion diagnostic assays for use with Five Prime’s…
Read More...

Ipsen announced a global licensing and joint development agreement for a pre-clinical oncology drug candidate discovered by researchers in MD Anderson’s Institute for Applied Cancer…
Read More...

Cloud Pharmaceuticals announced that they have entered into drug discovery collaboration with GlaxoSmithKline (GSK). Cloud will design novel small-molecule agents to GSK specified…
Read More...

Syndax Pharmaceuticals and Nektar Therapeutics announced a non-exclusive, clinical collaboration to evaluate the safety and efficacy of Nektar's NKTR-214, a CD122-biased agonist, in…
Read More...

SMi's 2nd annual Ophthalmic Drugs Conference returning to London, taking place at the Copthorne Tara Hotel in Kensington, on the 26th - 27th November 2018. As the global population…
Read More...

How would you feel if you were scheduled in for a operation only to hear that your surgeon was being replaced by a robot? Whilst this isn’t quite the stage machine intelligence in…
Read More...

Being the most talked about department within R&D,Cell & Gene Therapy will explore the latest advancements of advanced therapy medicinal products (ATMPs) by discussing, the…
Read More...

Shuwen Biotech announced that it has signed a partnership agreement with Bliss Biopharmaceutical Co., Ltd., a biopharmaceutical company engaged in the discovery, development and…
Read More...

Bayer announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) submitted by its collaboration partner Loxo Oncology, Inc. (NASDAQ: LOXO),…
Read More...